Stock 1093 CSPC PHARMACEUTICAL GROUP LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company CSPC Pharmaceutical Group Ltd.

Equities

1093

HK1093012172

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:03 2024-05-23 am EDT 		5-day change 1st Jan Change
6.44 HKD -1.08% Intraday chart for CSPC Pharmaceutical Group Ltd. -4.31% -11.29%
May. 17 CSPC Pharma Gets Clearance for China Clinical Trial of Drug for Metabolism-Related Diseases MT
May. 17 CSPC Pharmaceutical Group Limited Announces Recombinant Fully Human Anti-bKlotho Monoclonal Antibody Drug Obtains Approval from National Medical Products Administration of the People's Republic of China CI

Business Summary

CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows:

- drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%);

- vitamin C (10.1%);

- antibiotics (6.2%);

- other (5%): including anhydrous and raw caffeine.

Net sales are distributed geographically as follows: China (82.8%), Asia (7.2%), Europe (4.6%), the Americas (4.4%) and others (1%).

Number of employees: 23,500

Sales per Business

HKD in Million2022Weight2023Weight Delta
Finished Drugs
81.5 %
24,520 79.3 % 28,329 81.5 % +15.53%
Functional Food and Others
6.9 %
1,966 6.4 % 2,400 6.9 % +22.06%
Bulk Products - Vitamin C
6.1 %
2,529 8.2 % 2,132 6.1 % -15.70%
Bulk Products - Antibiotics
5.4 %
1,922 6.2 % 1,892 5.4 % -1.57%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
86.4 %
26,139 84.5 % 30,038 86.4 % +14.91%
Other Asian Regions
5.0 %
1,736 5.6 % 1,749 5.0 % +0.77%
Europe
4.1 %
1,268 4.1 % 1,411 4.1 % +11.27%
North America
2.8 %
-- 974 2.8 % -
Others
1.7 %
284 0.9 % 580 1.7 % +104.23%

Managers

Managers TitleAgeSince
Cui Long Zhang CEO
 Chief Executive Officer 55 95-12-31
Dong Chen Cai CHM
 Chairman 70 97-12-31
Hao Jiang BRD
 Director/Board Member 41 20-07-31
Zhen Guo Wang BRD
 Director/Board Member 54 12-01-19
Huai Yu Wang BRD
 Director/Board Member 61 09-12-31
Wei Dong Pan BRD
 Director/Board Member 55 05-12-31
Jin Xu Wang PRN
 Corporate Officer/Principal 53 13-06-09
Tai On Lo SEC
 Corporate Secretary 69 20-12-31

Members of the board

Members of the board TitleAgeSince
Dong Chen Cai CHM
 Chairman 70 97-12-31
Wei Dong Pan BRD
 Director/Board Member 55 05-12-31
Bo Wang BRD
 Director/Board Member 64 12-12-20
Cheuk Kin Law BRD
 Director/Board Member 61 21-03-07
Kin Man Chak BRD
 Director/Board Member 58 04-12-31
Zhen Guo Wang BRD
 Director/Board Member 54 12-01-19
Chun Lei Li BRD
 Director/Board Member - 17-12-11
Cui Long Zhang CEO
 Chief Executive Officer 55 95-12-31
Qingxi Wang BRD
 Director/Board Member 58 18-08-19
Hao Jiang BRD
 Director/Board Member 41 20-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,896,091,732 8,344,572,069 ( 70.15 %) 0 70.15 %

Shareholders

NameEquities%Valuation
Dong Chen Cai
23.63 %
2,817,375,670 23.63 % 2 334 M $
Common Success International Ltd.
6.113 %
728,796,313 6.113 % 604 M $
UBS Asset Management (Hong Kong) Ltd.
3.118 %
371,741,912 3.118 % 308 M $
BlackRock Fund Advisors
1.457 %
173,677,279 1.457 % 144 M $
UBS Asset Management Switzerland AG
0.9177 %
109,413,809 0.9177 % 91 M $
BlackRock Advisors (UK) Ltd.
0.7970 %
95,022,893 0.7970 % 79 M $
Bosera Asset Management Co., Ltd.
0.5853 %
69,782,000 0.5853 % 58 M $
China Asset Management Co., Ltd.
0.5155 %
61,464,480 0.5155 % 51 M $
UBS Asset Management (UK) Ltd.
0.3599 %
42,910,470 0.3599 % 36 M $
Zhong Ou Asset Management Co., Ltd
0.3238 %
38,600,000 0.3238 % 32 M $
NameEquities%Valuation
RhumbLine Advisers LP
0.000875 %
26,068 0.000875 % 86 833 $
Operose Advisors LLC
0.000068 %
2,030 0.000068 % 6 762 $
PNC Investments LLC
0.000007 %
208 0.000007 % 693 $

Holdings

NameEquities%Valuation
CSPC INNOVATION PHARMACEUTICAL CO., LTD.
100.00%
 157,520,510 100.00% 745,456,362 $
WUHAN YZY BIOPHARMA CO., LTD.
46.32%
 51,241,785 46.32% 48,809,850 $

Company contact information

CSPC Pharmaceutical Group Ltd.

No. 226 Huanghe Street

050035, Shijiazhuang

+86 31 1870 37015

http://www.cspc.com.hk
address CSPC Pharmaceutical Group Ltd.(1093)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for CSPC Pharmaceutical Group Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
6.44 HKD
Average target price
9.382 HKD
Spread / Average Target
+45.68%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CSPC PHARMACEUTICAL GROUP LTD. Stock CSPC Pharmaceutical Group Ltd.
-11.29% 9.88B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.69% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.28% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.49% 369B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.24% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.12% 282B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 244B
NOVARTIS AG Stock Novartis AG
+9.31% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-5.07% 205B
PFIZER, INC. Stock Pfizer, Inc.
-0.35% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 1093 Stock
  4. Company CSPC Pharmaceutical Group Ltd.